Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

« Older Entries
Newer Entries »

$GGX.ca GGX Gold Drilling Intersects 8.23 g/t Gold and 67.3 g/t Silver over 3.9 Meters at COD Vein — Gold Drop Property, Southern British Columbia $K.ca

Posted by AGORACOM at 9:28 AM on Thursday, August 9th, 2018

 

 

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564602/hub/ggx_large.png

    • Results received for 2018 drill holes COD18-37 to COD18-42 which tested the COD Vein.
    • COD18-37 Intersected 8.23 g/t Gold and 67.3 g/t Silver over 3.9 Meters at COD Vein

Vancouver, British Columbia (FSCwire) – GGX Gold Corp. (TSX-v: GGX), (OTCQB: GGXXF), (FRA: 3SR2) (the “Company” or “GGX”) is pleased to announce it has received additional analytical results from its diamond drilling program on the Gold Drop property, located near Greenwood, B.C. Drill core analytical results have been received for 2018 drill holes COD18-37 to COD18-42 which tested the COD Vein. The COD gold bearing vein is located in the Gold Drop Southwest Zone.

 

Core from drill hole COD18-37 (includes 8.23 g/t gold over 3.95m intersection) (To view the graphic in its original size, please click here)

 

A highlight from these analytical results is an intersection of 8.23 grams per tonne (g/t) gold, 67.36 g/t silver and 38.53 g/t tellurium over 3.95 meter core length in drill hole COD18-37. This gold-bearing interval (quartz veins and altered granodiorite) in COD18-37 is located at approximately 40 meter vertical depth and approximately 130 meters southwest of the area of 2017 trenching.  COD18-37 is located approximately 190 meters southwest of hole COD17-14 which intersected the 4.59 g/t gold over 16.03 meters, including 10.96 g/t gold over 5.97 meters (News Release of September 7, 2017).

 

Gold bearing quartz vein in drill hole COD18-37 (To view the graphic in its original size, please click here)

 

The 2018 drilling program to date has been mainly focused on testing and defining the COD Vein, a Dentonia/Jewel style quartz vein. Trenching during 2017 exposed the northeast – southwest striking COD Vein for over 160 meter strike length. The 2018 drilling program has also tested the continuation of the Everest Vein, which is located approximately 600 meters southwest of the COD Vein worksite. The Everest Vein was first discovered by Company prospectors during the 2017. Chip samples collected in 2017 across the approximate 0.4 meter wide vein exposure returned up to 52.8 g/t gold and 377 g/t silver while a grab sample of a quartz vein boulder broken off the outcrop by the excavator returned 81.8 g/t gold and 630 g/t silver (News Release of August 21, 2017).

 

Previous drill core analytical results from the 2018 drilling program are reported in News Releases of May 29, June 14, June 27, July 11, July 19, July 25 and August 1. The highlight of the 2018 drilling program to date is 14.62 g/t gold, 150.2 g/t silver and 102.0 g/t tellurium over 2.1 meter core length in drill hole COD18-3 at the COD Vein.

 

The analytical results listed below are highlights from drill holes COD18-37 to COD18-42 (intersections greater than 1 g/t gold), testing the continuation of the COD Vein south-southwest of the 2017 trench. Since true widths cannot be accurately determined from the information available the core lengths (meters) are reported. The gold, silver and tellurium analyses are reported in grams per tonne (g/t). The intervals listed in the following table are from the gold, silver and tellurium bearing quartz veins and adjacent altered granodiorite in drill hole COD18-37 and a quartz vein in drill hole COD18-42.

 

Hole ID From (m) To (m) Interval Length (m) Au (g/t) Ag (g/t) Te (g/t)
COD18-37 47.22 51.17 3.95 8.23 67.36 38.53
including 47.22 47.54 0.32 21.8 165 101.5
including 48.03 48.32 0.29 3.35 26.7 18
including 48.32 49.00 0.68 2.05 23.2 17.8
including 49.00 50.05 1.05 18.15 137 76
including 50.05 50.38 0.33 5.05 56.7 25.6
including 50.38 51.17 0.79 3.02 32.6 16.9
COD18-42 41.18 41.53 0.35 6.58 52 23.1

 

To view the graphic in its original size, please click here

 

Drill core from the 2018 program was geologically logged and sampled. Drill core was sawn in half with half core samples submitted for analysis and remaining half core stored in a secure location. Core samples were delivered to the ALS Minerals laboratory in Vancouver to be analyzed for gold by Fire Assay – AA. The samples were also analyzed for 48 Elements by Four Acid ICP-MS. Samples exceeding 100 g/t silver were re-analyzed by Four Acid ICP-AES. Quality control (QC) samples were inserted at regular intervals.

 

David Martin, P.Geo., a Qualified Person as defined by NI 43-101, is responsible for the technical information contained in this News Release.

 

To view the Original News release with pictures please go to the website or contact the company.

 

On Behalf of the Board of Directors,

Barry Brown, Director

604-488-3900

[email protected]

 

Investor Relations:

Mr. Jack Singh, 604-488-3900   [email protected]

 

“ We don’t have to do this, we get to do this ”

The Crew

 

Tags: , , , ,
Posted in All Recent Posts, Small and Micro-Cap Space | Comments Off on $GGX.ca GGX Gold Drilling Intersects 8.23 g/t Gold and 67.3 g/t Silver over 3.9 Meters at COD Vein — Gold Drop Property, Southern British Columbia $K.ca

Health Canada Gives Green Light to Tetra Bio-Pharma’s $TBP.ca #Cannabis Vs. #Fentanyl Trial $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:18 AM on Thursday, August 9th, 2018

  • Health Canada has approved its protocol for a clinical trial investigating its PPP001 drug as an alternative to the opioid fentanyl in the management of breakthrough cancer pain
  • The clinical trial will be conducted by Montreal-based Santé Cannabis, a medical clinic and contract research organization specialized in clinical research for cannabis – based therapies

Patient recruitment to begin for landmark research

ORLEANS, Ontario, Aug. 09, 2018 — Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that Health Canada has approved its protocol for a clinical trial investigating its PPP001 drug as an alternative to the opioid fentanyl in the management of breakthrough cancer pain.  The clinical trial will be conducted by Montreal-based Santé Cannabis, a medical clinic and contract research organization specialized in clinical research for cannabis – based therapies.

The trial will assess the time-to-relief in patients suffering from breakthrough cancer pain.  Based on its clinical data, Tetra believes that the pharmacodynamic properties of PPP001 may provide a novel faster acting alternative to the opioid fentanyl.  In addition, the time-to-maximal plasma concentrations of THC suggest that PPP001 will provide rapid relief to the patient’s suffering.  As a prescription drug with a Drug Identification Number (DIN) PPP001 will be eligible for insurance coverage, making the cannabis-based medication accessible in pharmacies thereby providing much easier access.

The Opioid Crisis

There have been numerous news reports in the North America media highlighting the fact that we are experiencing an opioid crisis. In June, the Canadian government asked drug makers to stop marketing opioids, but for patients suffering from uncontrolled pain, this news does not provide them with an alternative to alleviate their pain.

  • There were 41,997 opioid-related deaths in the USA in 2016 contributing to the U.S. President’s declaration that the U.S. is experiencing an opioid crisis.
  • 92% of the 3,987 apparent opioid-related deaths in Canada in 2017 were accidental.
  • Males make up 76% of these fatalities; more than one-third among those aged 30-39.
  • The percentage of these accidental deaths involving fentanyl rose from 55% in 2016 to 72% in 2017.

“Medical cannabis may help reduce the use of drugs like fentanyl for treating breakthrough and chronic pain. However, unrefuted scientific data on its safety and effectiveness that will satisfy regulators, professional groups and insurers is what’s missing,” said Dr. Guy Chamberland, Interim CEO and Chief Scientific Officer of Tetra Bio-Pharma.  “Tetra is in the business of providing that evidence which would see our drug PPP001 become a complementary prescription therapy.  We’ve taken a pharmaceutical pathway of drug development involving collaborative dialogue with Health Canada and the FDA to bring cannabis and cannabinoid products to market so that physicians, who have been hesitant to recommend it, will have a new, trusted therapeutic option for their patients.”

Cannabis versus Fentanyl Clinical Trial Recruitment
Santé Cannabis will begin recruitment for the clinical trial as of October 2018. More information on eligibility criteria as well as the details and duration of the trial can be obtained by visiting the Santé Cannabis website: www.santecannabis.ca/en/research/cannabis-clinical-trial/ or by calling 514-419-4131 and select English and press 5 to reach the research team.

About Tetra Bio-Pharma
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

For more information visit: www.tetrabiopharma.com

About Santé Cannabis
Established in Montreal, Quebec in 2014, Santé Cannabis is a Centre of Excellence in medical cannabis research, clinical practice and healthcare professional training. Since its inception, Santé Cannabis has provided medical assessment, education, monitoring and follow-up to 5,000 patients referred by more than 2,000 Quebec physicians. Santé Cannabis operates within the guidelines for the authorization of medical cannabis as set out by the Collège des médecins du Québec.   As an independently credentialed clinical trial research organization, and with unparalleled clinical experience supporting both patients and healthcare professionals, Santé Cannabis has established itself as a global leader in medical cannabis research. Santé Cannabis is currently conducting a Health Canada approved Phase 3 trial for PPP001 for advanced cancer patients suffering from uncontrolled pain and associated symptoms, as well as a Phase 2 trial for PPP005 investigating the use of oral capsules of cannabis oil for the treatment of chronic pain.

For more information visit:  www.santecannabis.ca

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, including this trial, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

For further information, please contact Tetra Bio-Pharma Inc.

Robert (Bob) Bechard
Executive Vice President, Corporate Development and Licensing
514-817-2514
[email protected]

Media Contact:
energi PR
Stephanie Engel
[email protected]
514-288-8500 ext. 209
416-425-9143 ext. 209

Tags: , , , , , ,
Posted in All Recent Posts | Comments Off on Health Canada Gives Green Light to Tetra Bio-Pharma’s $TBP.ca #Cannabis Vs. #Fentanyl Trial $AERO $CBDS $CGRW $APH.ca $GBLX

St-Georges Eco-Mining $SX $SX.ca $SXOOF Announces #Lithium Extraction Technology Licensing Agreement with Hipo Resources Ltd. for DRC Project

Posted by AGORACOM-JC at 4:27 PM on Wednesday, August 8th, 2018

Sx large

  • Signed a binding term sheet with Hipo Resources Ltd (ASX: HIP), a public company based in Australia
  • In consideration for the R&D, which will include engineering services, and once a definitive agreement has been entered into, Hipo Resources Ltd. will issue to St-Georges up to 27,000,000 common shares of its capital stock.

Montreal, Quebec /  August 8, 2018 – St-Georges Eco-Mining Ltd. (CSE: SX) (OTC: SXOOF) (FSE: 85G1) is pleased to announce that it has signed a binding term sheet with Hipo Resources Ltd (ASX: HIP), a public company based in Australia.

St-Georges has agreed to provide research and development utilizing products, extraction methods and proprietary technology to develop Hipo’s Democratic Republic of Congo lithium project in separation, recovery, and purification of lithium from its lithium-bearing material.

In consideration for the R&D, which will include engineering services, and once a definitive agreement has been entered into, Hipo Resources Ltd. will issue to St-Georges up to 27,000,000 common shares of its capital stock. The issuance will be done in stages over a 36-month period commencing on the date of execution of the definitive agreement, contingent on St-Georges reaching certain performance benchmarks over the 36-month period according to the schedule below:

1,500,000 shares at signing

8,500,000 shares at Stage 1 Benchmark completion: which is defined by the delivery of an independent laboratory report commissioned by St-Georges, indicating positive viable lithium recoveries.

8,500,000 shares at Stage 2 Benchmark completion: defined by independent report describing results of initial pilot mining operations and the processing of a minimum of one (1) metric ton in a simulated industrial environment.

8,500,000 shares at Stage 3 Benchmark completion: defined by the receipt of either: a Preliminary Economical Assessment Report (PEA); a commercialization decision; the third (3rd) year anniversary of this agreement assuming all other issuances have been made.

St-Georges has agreed that shares issued will be subject to a 36 months escrow period.

The Parties will establish a royalty stream on the commercial output of the Kamola Lithium Project for the entire mine life subject to Hipo using St-Georges technology, which will be opposable to any successors of Hipo as a lien on the mining assets. St-Georges and Hipo will negotiate a right of first refusal in favour of Hipo. The royalty, of which further details will be defined in the definitive agreement within the guidelines of the “Royalty Formula” of the binding term sheet, will take the form of a 5% Net Revenue Interest or Net Revenue Return.

A further news release will be disseminated once the definitive agreement has been concluded. The definitive agreement will be subject to acceptance of the board of directors of both companies and subject to review by regulatory authorities.

Enrico Di Cesare, VP, Metallurgy & Director of St-Georges commented “St-Georges continues to apply innovation with known technologies coupled with newly developed technologies to address gaps for the recovery of non-traditional lithium resources. Our focus remains greener, less chemicals and more usable by-products unlocking value in non-traditional resources as the next generation of lithium supply to the growing battery market and its needs for this commodity.

Di Cesare further stated “Innovation is being applied to concentrating Lithium in Bonnie Claire clay in Nevada USA, which is owned by Iconic Minerals Ltd (TSX-V: ICM). In addition, St-Georges is also looking to initiate development with similar strategies for hard rock deposits in North America and other parts of the world. We do value and look forward to working with Hipo Resources in advancing the lithium potential of their DRC project.”

ON BEHALF OF THE BOARD OF DIRECTORS

“Enrico Di Cesare”

ENRICO DI CESARE, DIRECTOR, VICE-PRESIDENT RESEARCH & DEVELOPMENT

About St-Georges

St-Georges is developing new technologies to solve the some of the most common environmental problems in the mining industry. The Company controls directly or indirectly, through rights of first refusal, all the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Head quartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Tags: , , , , ,
Posted in All Recent Posts, Featured, Small Cap Lithium Stocks, St Georges Eco-Mining Technologies | Comments Off on St-Georges Eco-Mining $SX $SX.ca $SXOOF Announces #Lithium Extraction Technology Licensing Agreement with Hipo Resources Ltd. for DRC Project

CLIENT FEATURE: Star Navigation $SNA.ca Real-Time Flight Tracking and Monitoring Technology

Posted by AGORACOM-JC at 4:15 PM on Wednesday, August 8th, 2018

STAR-A.D.S.®

  • On-board real-time monitoring and data analysis system that provides a “virtual window into an aircraft”
  • As cost-effective air to ground communication system that automatically and securely transmits flight data and incident alerts.
  • Continuously monitors selected avionics systems on the aircraft from power-on to power-off, instantly analyzes the data, and transmits selected data and any incident alerts, via satellite to the operator.
  • Acts as an early warning system, detecting the earliest signs of potential problems
  • Performs these functions in “real-time” providing essential safety monitoring to the benefit of passengers, aircraft personnel, and ground crew
  • Applications include: Commercial Airlines, Helicopters, Business Aircraft, Assist Search and Rescue by providing last transmitted location
  • Recent applications: Emergency Medical Services (airborne and ground vehicles), Land vehicles

CHECK OUT RECENT INTERVIEW

FULL DISCLOSURE: Star Navigation Systems Group Ltd. is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Star Navigation Systems (SNA:TSXV) | Comments Off on CLIENT FEATURE: Star Navigation $SNA.ca Real-Time Flight Tracking and Monitoring Technology

Tetra Bio-Pharma’s $TBP.ca Dr. Chamberland to Announce Health Canada’s Green Light for the #Cannabis vs. #Fentanyl Trial $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 2:26 PM on Wednesday, August 8th, 2018

Logo tetrabiopharma rgb web

  • Announced that Health Canada has approved its protocol for a clinical trial investigating its PPP001 drug as an alternative to the opioid fentanyl in the management of breakthrough cancer pain
  • Dr. Guy Chamberland, Interim CEO and Chief Scientific Officer will provide additional details on TVA’s Gatineau 6:00 p.m. ET News Program

ORLEANS, Ontario, Aug. 08, 2018 – Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that Health Canada has approved its protocol for a clinical trial investigating its PPP001 drug as an alternative to the opioid fentanyl in the management of breakthrough cancer pain. Dr. Guy Chamberland, Interim CEO and Chief Scientific Officer will provide additional details on TVA’s Gatineau 6:00 p.m. ET News Program. A more detailed press release will be issued tomorrow.

About Tetra Bio-Pharma
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com

More information at: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, including this trial, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

For further information, please contact Tetra Bio-Pharma Inc.

Robert (Bob) Bechard
Executive Vice President, Corporate Development and Licensing
514-817-2514
[email protected]

Media Contact:
energi PR
Stephanie Engel
[email protected]
514-288-8500 ext. 209
416-425-9143 ext. 209

Tags: , , , , ,
Posted in All Recent Posts, Featured, Tetra Bio-Pharma Inc. | Comments Off on Tetra Bio-Pharma’s $TBP.ca Dr. Chamberland to Announce Health Canada’s Green Light for the #Cannabis vs. #Fentanyl Trial $AERO $CBDS $CGRW $APH.ca $GBLX

It’s ‘inevitable’ that #Esports will be part of the Olympics, Logitech CEO says $GMBL $ATVI $TTWO $GAME $EPY.ca $TCEHF $Game.ca $EPY.ca

Posted by AGORACOM-JC at 10:42 AM on Wednesday, August 8th, 2018
  • It’s “inevitable” that esports will someday be part of the Olympics, Logitech CEO Bracken Darrell tells CNBC’s Jim Cramer.
  • It could even be “the biggest sport in the world,” Darrell tells the “Mad Money” host.

It’s “inevitable” that competitive video gaming, also known as esports, will someday be part of the Olympics, Logitech International President and CEO Bracken Darrell told CNBC on Tuesday.

Darrell, whose company makes computer and mobile phone accessories and has begun to sponsor top esports teams, told “Mad Money” host Jim Cramer that Logitech met with the International Olympic Committee two weeks ago.

Held in Lausanne, Switzerland, where Logitech is headquartered, the meeting revolved around “how and when” esports should come to the Olympics, Darrell said.

“I think it’s inevitable. I think it will be part of the Olympics,” Darrell said on Tuesday.

“I’ll make another prediction which it’ll be hard to hold me to unless you have me on the show in 10 years or 20 years, but I think it’ll be the biggest sport in the world,” the CEO added.

Competitive gaming has swept the country as high schools and universities warm up to the idea of creating programs and scholarships for students who excel at games like Activision Blizzard’s Overwatch and Riot Games’ League of Legends.

University of California, Irvine, whose acting esports program director Mark Deppe appeared on “Mad Money” in January, was one of the first universities to offer esports scholarships, awarding gamers $5,610 and $2,500 to join its League of Legends and Overwatch teams, respectively.

Logitech is a partial sponsor for UCI’s program, providing high-end gear for the school’s esports facility.

“Scholarships are starting to spread across the university system,” Darrell told Cramer. “My brother’s a college president, Kentucky Wesleyan College. It’s a small liberal arts college. They’re putting in gaming as not a varsity sport yet, but a club sport. It’s coming everywhere.”

And that trend drives sales at Logitech, which in late July reported first-quarter earnings with more than 60 percent growth in its Gaming and Video Collaboration categories.

Darrell added that video gaming has reignited growth in his company’s webcam business, which is seeing double-digit gains as gamers and bloggers seek higher quality video equipment to film themselves playing games.

“In 1965, 1968, 1969, I remember the NFL and the Super Bowl, how big it seemed then. Looking back on that, it was tiny,” the CEO said. “I think that’s exactly where we are now in gaming.”

Shares of Logitech closed up slightly on Tuesday, logging a 0.13 percent gain and settling at $45.79 a share. In its July earnings report, the company said it would acquire microphone maker Blue Microphones for $117 million in cash.

Source: https://www.cnbc.com/2018/08/07/logitech-ceo-its-inevitable-that-esports-will-be-part-of-olympics.html

Tags: , , , , ,
Posted in All Recent Posts, Esports Entertainment Group, Esports Entertainment Group Inc., eSports Investing | Comments Off on It’s ‘inevitable’ that #Esports will be part of the Olympics, Logitech CEO says $GMBL $ATVI $TTWO $GAME $EPY.ca $TCEHF $Game.ca $EPY.ca

#Nickel’s steely resolve shines through for miners at this year’s Diggers & Dealers $TN.ca $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 9:34 AM on Wednesday, August 8th, 2018
  • As the global economic outlook continues to improve, the unmissable overarching theme at this year’s Diggers & Dealers has been nickel’s turnaround, with most analysts, miners and explorers alike believing the commodity’s upturn has only just begun.
  • The fundamentals for nickel look excellent going forward

Panoramic Resources (ASX: PAN) managing director Peter Harold told Small Caps he noticed the nickel market had “tightened materially” throughout the first half of this year, underpinned by slipping London Metals Exchange stockpiles which have dropped from more than 350,000t to about 250,000t.

“The fundamentals for nickel look excellent going forward,” he said.

“On the demand side, stainless steel consumption is growing year-on-year and demand for nickel sulphate in electric vehicle batteries is forecast to grow strongly.”

Mr Harold added the supply/demand deficit for nickel this year was anticipated to hit a “record” 200,000t or more.

“Further deficits are forecast for the foreseeable future,” he noted.

“While the current trade war rhetoric has had a negative impact on all base metal prices over the past few months the nickel fundamentals are unchanged. I have seen nickel price forecasts of between US$8-10/lb for 2019-2021, which would seem plausible if the supply deficits continue.”

Deutsche Bank has predicted nickel will end 2018 at around US$7.02/lb and jump to US$8.42/lb in 2019, then climb to US$9.45/lb in 2020.

In the past 12 months, nickel has picked itself off the ground and staged a come back, with the price rising from around US$4.50/lb to its current level of about US$6/lb after pushing past US$7/lb in April and June.

Commenting on the nickel price, Western Areas (ASX: WSA) managing director Dan Lougher said it was “still a bit wobbly”, but that “times were changing” for nickel, due to its consumption within the growing electric vehicle and lithium-ion battery sectors.

Rox Resources (ASX: RXL) managing director Ian Mulholland told Small Caps nickel had clearly been the star commodity in the last 12 months.

And as a result, he said investor interest in the company’s high-grade nickel sulphide assets had “absolutely” increased.

He added he anticipated this would continue as demand for the commodity continues its upward trajectory and London Metals Exchange stockpiles carry on diminishing.

Meanwhile, financial services company UBS has reported that nickel was its “preferred play” during the next 12 months due to its uptake in electric vehicle batteries, with demand “rapidly rising”.

If the nickel sentiment at this year’s Diggers & Dealers is anything to go by, then nickel stocks will be one to watch in the coming months.

Source: https://smallcaps.com.au/nickel-steely-resolve-shines-miners-diggers-dealers/

Tags: , , , ,
Posted in All Recent Posts, Tartisan Nickel | Comments Off on #Nickel’s steely resolve shines through for miners at this year’s Diggers & Dealers $TN.ca $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

96% of heavily engaged US #gamers play on #mobile $KUU.ca $TCEHY $ATVI $CYOU

Posted by AGORACOM-JC at 4:06 PM on Tuesday, August 7th, 2018
  • Super Gamer segment represents 13% of the total US gaming market, is 2/3 male (64% male, 36% female)
  • skews fairly young (average age 25.7, relative to the total market average of 32)

There’s a lingering misconception in the industry that mobile gaming is for casual, uninvested non-gamers while PCs, consoles, and handhelds are where the “real” gamers spend their time.

In its Gamer Segmentation report, EEDAR surveyed 5,000 US gamers and, using k-means clustering analysis, classified them into 6 separate segments based on their gaming habits, interests and investment across the platforms they play on.

One of the segments identified during the analysis are the Super Gamers – heavily engaged players who game extensively on multiple platforms. The Super Gamer segment represents 13% of the total US gaming market, is 2/3 male (64% male, 36% female) and skews fairly young (average age 25.7, relative to the total market average of 32). For these voracious players, gaming is a major hobby – taking up an average of 26 total hours a week, which is about 23% of their total entertainment time.

Where many segments specialize in a particular platform (or platforms), the Super Gamer audience is likely to spread their gaming time around between platforms. 78% of these gamers play on three or more platforms (possible platforms including mobile, PC, console and handheld), and for most, mobile is one of them – 96% of Super Gamers play games on a smartphone or tablet.

Within this segment, EEDAR found that Super Gamers were as likely to play on mobile as they were on PC.

[Note: For purpose of this analysis, the Nintendo Switch was classified as a console.]

Despite the high playership (and spend) on mobile, it’s critical to note that Super Gamers are using mobile as a supplement to – and not replacement for – HD/PC gaming experiences. When asked to provide their reasons for engaging with mobile, Super Gamers’ responses emphasized its convenience and cited its low amount of required attention:

● Can play anywhere
● Device is convenient
● It’s cheap or free
● Easy to pick up / put down
● Allows for multitasking

All of this suggests that Super Gamers will turn to the platforms available to them to indulge the gaming urge that strikes at a given moment.

When out and about, or watching TV, they’re likely to turn to mobile games for entertainment. When at home, and when the opportunity for a focused play session arises, they’ll turn to PC or Console. In situations between these extremes, they are likely to indulge in handheld play.

Source: https://www.gamesindustry.biz/articles/2018-08-07-96-percent-of-heavily-engaged-us-gamers-play-on-mobile-eedar

Tags: , , , , , ,
Posted in All Recent Posts | Comments Off on 96% of heavily engaged US #gamers play on #mobile $KUU.ca $TCEHY $ATVI $CYOU

#ProgrammaticAd Buying Grows Steadily; #Amazon Top Spender $GOOD.ca $TTD $RUBI $AT.ca $TRMR $FUEL

Posted by AGORACOM-JC at 2:46 PM on Tuesday, August 7th, 2018
  • A recent study conducted by MediaRadar examined the state of programmatic ad buying in Q1 2018.
  • Found that three-quarters of all brands tracked placed programmatic ads during the timeframe, keeping the format on a steady growth path even with concerns about brand safety and transparency

BY Steven Wong

Additionally, MediaRadar found that, of the top 50 programmatic spenders, 94 percent were brands that were in the top 50 in 2017; these include Walmart, Microsoft and Verizon. Native programmatic ad buying is helping to drive growth, and spending on native ads placed programmatically increased by 10 percent year-over-year. Programmatic solves native’s two biggest issues, scale and an intensive sales process.

“The growth of native programmatic ads is two-fold,” MediaRadar CEO and co-founder Todd Krizelman told AList. “Native is up as a whole as more brands are finding the benefits of placing these ads, and the technology programmatic companies have to place native has also gotten better.”

Newcomers to the top 50 programmatic spenders include Progressive Insurance and Gap. Meanwhile, the top 10 companies comprised about 37 percent of the total spend for the group. Amazon ranked at the top at the top of the list, accounting for 10 percent of the total ad spend, which is 1.5x more than the second-place spender Microsoft.

The top 10 programmatic advertisers according to the MediaRadar study are:

  1. Amazon
  2. Microsoft
  3. Wayfair
  4. TaxAct
  5. Charles Schwab
  6. Weight Watchers
  7. Sprint
  8. Coors Light
  9. Geico
  10. Dell

Krizelman stated in the report that, “Despite concerns over transparency, advertisers continue to invest in programmatic. It is the preferred method for transacting media for many advertisers and it doesn’t appear to be changing.”

According to forecasts from eMarketer, $46 billion will be spent on programmatic advertising by the end of this year, with 82.5 percent of digital display ads in the US purchased through automated channels.

Source: https://www.alistdaily.com/technology/programmatic-ad-spending-grows-steadily/

Tags: , , , ,
Posted in All Recent Posts, Good Life Networks | Comments Off on #ProgrammaticAd Buying Grows Steadily; #Amazon Top Spender $GOOD.ca $TTD $RUBI $AT.ca $TRMR $FUEL

#Mercedes launches #Esports squad, signs 2017 #F1 champion Leigh $GMBL $ATVI $TTWO $GAME $EPY.ca $TCEHF $Game.ca $EPY.ca

Posted by AGORACOM-JC at 10:35 AM on Tuesday, August 7th, 2018

  • Mercedes has announced inaugural Formula 1 eSports champion Brendon Leigh as a driver for its brand-new virtual racing team.
  • Leigh, who defeated Fabrizio Donoso Delgado and Sven Zurner in a controversial final last year, will defend his drivers’ championship with Mercedes

“The pressure is somewhat enormous to defend this championship,” Leigh told Autosport earlier this year.

“I’m going to walk into the finals with the biggest target on my back that I’ve ever had in my life. The intensity has risen tenfold.”

The 19-year-old will compete alongside 2017 McLaren World’s Fastest Gamer finalist Harry Jacks, multiple-Polish sim racing champion Patryk Krutyi and Dani Bereznay, who was selected by the team in July’s Pro Draft.

The team will be based at Brackley alongside its real-life F1 team.

It will use a “purpose-built eSports training centre, which will provide the team’s gamers with state-of-the-art facilities and equipment to develop their skills,” according to Mercedes a statement.

The eSports team will be based in the same building as Mercedes’ ‘F1 Driver in Loop Simulator’.

“The eSports programme will benefit from transferable elements pertinent to optimising car set-up and honing racecraft,” the statement continued.

“The programme also focuses on human performance and will give the eSports team members access to the on-site Performance Centre covering the core areas of nutrition, physical conditioning and wellbeing that support the gamers in reaching their full potential.”

Subscribe to Autosport Plus

Premium motorsport journalism in an
ad-free experience.

Subscribe today

The quartet will start competing in October in the next stage of the F1 2018 eSports series.

F1 eSports 2018 line-up so far

Mercedes AMG Petronas Motorsport
Brendon Leigh, Harry Jacks, Patryk Krutyi, Daniel Bereznay

Red Bull Racing eSports
Joni Tormala, Graham Carroll

Renault Sport Team Vitality
Sven Zurner, Kimmy Larsson, James Doherty

Haas F1
Martin Stefanko, Michal Smidl Hype Energy

eForce India
Fabrizio Donoso Delgado, Mads Sorensen, Marcel Kiefer

McLaren Shadow
Olli Pahkala

Toro Rosso
Cem Bolukbasi, Patrick Holzmann Sauber Salih Saltunc, Allert van der Wal, Sonuc Saltunc

Williams eSports
Tino Naukkarinen

Source: https://www.autosport.com/gaming/news/137898/mercedes-launches-official-f1-esports-squad

Tags: , , , , ,
Posted in All Recent Posts, Esports Entertainment Group, Esports Entertainment Group Inc., eSports Investing | Comments Off on #Mercedes launches #Esports squad, signs 2017 #F1 champion Leigh $GMBL $ATVI $TTWO $GAME $EPY.ca $TCEHF $Game.ca $EPY.ca

« Older Entries
Newer Entries »